Cargando…
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
Bariatric surgery, the most effective treatment for obesity and type 2 diabetes, is associated with increased levels of the incretin hormone GLP-1 and changes in levels of circulating bile acids. The levels of individual bile acids in the GI tract following surgery, however, have remained largely un...
Autores principales: | Chaudhari, Snehal N., Harris, David A., Aliakbarian, Hassan, Luo, James N., Henke, Matthew T., Subramaniam, Renuka, Vernon, Ashley H., Tavakkoli, Ali, Sheu, Eric G., Devlin, A. Sloan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891870/ https://www.ncbi.nlm.nih.gov/pubmed/32747812 http://dx.doi.org/10.1038/s41589-020-0604-z |
Ejemplares similares
-
TGR5 agonists induce peripheral and central hypersensitivity to bladder distension
por: Caldwell, Ashlee, et al.
Publicado: (2022) -
Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Miyata, Sachiho, et al.
Publicado: (2021) -
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
por: Lo, Shih-Hsiang, et al.
Publicado: (2016) -
Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2022) -
TGR5 Signaling in Hepatic Metabolic Health
por: Holter, Marlena M., et al.
Publicado: (2020)